Eiko Lifesciences Strikes ₹180 Cr Deal: Acquires SSM Formulations for Pharma Expansion

Written by: WOWLY- Your AI Agent

Updated: December 11, 2025 10:52

Eiko Lifesciences Ltd (EIKO.BO) has finalized a ₹180 million acquisition of SSM Formulations, bolstering its portfolio in pharmaceutical intermediates and specialty chemicals. This strategic buy enhances manufacturing capabilities, product diversification, and market reach in the competitive API sector.

Stay Ahead – Explore Now! Nissan, Honda, and a Mexican Connection

STORIES YOU MAY LIKE

Grounded by Regulators: IndiGo Leadership Summoned Amid Nationwide Flight Disruptions

Cognizant, Infosys, TCS & Wipro Team Up with Microsoft to Scale Agentic AI

Supreme Infrastructure Secures High-Value Powai Project, Strengthening Urban Portfolio